614 filings
Page 7 of 31
DEFA14A
NBSE
NeuBase Therapeutics Inc
2 Jul 21
Additional proxy soliciting materials
7:06am
DEF 14A
NBSE
NeuBase Therapeutics Inc
Definitive proxy
2 Jul 21
7:01am
CORRESP
NBSE
NeuBase Therapeutics Inc
2 Jul 21
Correspondence with SEC
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
1 Jul 21
Letter from SEC
12:00am
S-3
NBSE
NeuBase Therapeutics Inc
Shelf registration
23 Jun 21
5:21pm
4
NBSE
NeuBase Therapeutics Inc
21 Jun 21
NeuBase Therapeutics / DOV A MD GOLDSTEIN ownership change
11:03am
8-K
NBSE
NeuBase Therapeutics Inc
8 Jun 21
Regulation FD Disclosure
2:01pm
4
Sandra Rojas-Caro
25 May 21
NeuBase Therapeutics / Sandra Rojas-Caro ownership change
4:13pm
4
Kianoush Motesharei
25 May 21
NeuBase Therapeutics / Kianoush Motesharei ownership change
4:12pm
3
Sandra Rojas-Caro
25 May 21
NeuBase Therapeutics / Sandra Rojas-Caro ownership change
4:10pm
3
Kianoush Motesharei
25 May 21
NeuBase Therapeutics / Kianoush Motesharei ownership change
4:10pm
8-K
NBSE
NeuBase Therapeutics Inc
25 May 21
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
9:00am
8-K
NBSE
NeuBase Therapeutics Inc
20 May 21
NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer
9:00am
10-Q
2021 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 May 21
12:00am
4
Gerald J McDougall
13 May 21
NeuBase Therapeutics / Gerald J McDougall ownership change
6:03pm
3
Gerald J McDougall
13 May 21
NeuBase Therapeutics / Gerald J McDougall ownership change
6:02pm
8-K
NBSE
NeuBase Therapeutics Inc
13 May 21
NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021
4:32pm
8-K
NBSE
NeuBase Therapeutics Inc
12 May 21
NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors
4:30pm
8-K
NBSE
NeuBase Therapeutics Inc
30 Apr 21
Other Events
5:01pm
4
NBSE
NeuBase Therapeutics Inc
27 Apr 21
NeuBase Therapeutics / ERIC I RICHMAN ownership change
4:03pm